DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Gilead Sciences News

Gilead’s Kite Pharma Acquires Interius for $350 Million to Advance In Vivo CAR-T Therapies Amid 2025 Buyout Race

Gilead’s Kite Pharma Acquires Interius for $350 Million to Advance In Vivo CAR-T Therapies Amid 2025 Buyout Race

18

4 months ago

European Commission Approves Gilead’s Twice-Yearly Lenacapavir Injection With Nearly 100% Efficacy for HIV Prevention Across EU

European Commission Approves Gilead’s Twice-Yearly Lenacapavir Injection With Nearly 100% Efficacy for HIV Prevention Across EU

22

3 months ago

CVS Delays Coverage of Gilead’s New HIV Prevention Shot

10

4 months ago

Latest stories

Aug 27, 2025
Aug 27, 2025
Europe
Health
Pharma
European Commission Approves Gilead’s Twice-Yearly Lenacapavir Injection With Nearly 100% Efficacy for HIV Prevention Across EU
Authors
22
3 months ago
Aug 21, 2025
Aug 21, 2025
Pharma
Business
Science
Gilead’s Kite Pharma Acquires Interius for $350 Million to Advance In Vivo CAR-T Therapies Amid 2025 Buyout Race
Authors
18
4 months ago
Aug 21, 2025
Aug 21, 2025
Pharma
Business
Science
CVS Delays Coverage of Gilead’s New HIV Prevention Shot
Authors
10
4 months ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join